FIELD: virology.
SUBSTANCE: proposed is influenza virus strain B / 60 / Colorado / 2017/1 (Victoria Line). It was obtained on the basis of the epidemic virus B / Colorado / 06/17 (Victoria line) and a cold-adapted attenuation donor B / USSR / 60/69, harmless to humans. The claimed strain is characterized by temperature sensitivity and cold adaptation, harmlessness to laboratory animals. The strain contains genes encoding the surface proteins of the influenza virus hemagglutinin (HA) and neuraminidase (NA), inherited from an antigenically relevant circulating epidemic strain, and the remaining six genes encoding internal and non-structural proteins (PB2, PB1, PA, NP, M, NS) from an attenuation donor harmless to humans.
EFFECT: strain B / 60 / Colorado / 2017/1 (Victoria Line) can be used in medicine to prevent the incidence of influenza among adults and children as part of a live influenza intranasal vaccine.
1 cl, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| VACCINE STRAIN OF INFLUENZA VIRUS B/60/HONG KONG/ 2017/5584 (VICTORIA LINE) FOR THE PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2021 |
|
RU2757396C1 |
| REASSORTANT STRAIN OF INFLUENZA VIRUS B/60/WASHINGTON/2019/3676 (VICTORIA LINE) FOR THE PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2021 |
|
RU2757397C1 |
| VACCINE STRAIN OF INFLUENZA VIRUS A/17/BRISBANE/2017/7178 (H3N2) FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2019 |
|
RU2711101C1 |
| REASSORTANT STRAIN OF INFLUENZA VIRUS A/17/VICTORIA/2019/276 (H1N1) PDM09 FOR THE PRODUCTION OF LIVE INTRANASAL INFLUENZA VACCINE FOR ADULTS AND CHILDREN | 2022 |
|
RU2783878C1 |
| VACCINE STRAIN OF INFLUENZA A/17/KANSAS/2017/631 (H3N2) VIRUS FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2019 |
|
RU2732610C1 |
| VACCINE STRAIN OF INFLUENZA VIRUS A/17/SWITZERLAND/2017/51 (H3N2) FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2019 |
|
RU2715674C1 |
| VACCINE STRAIN OF INFLUENZA VIRUS A/17/BRISBANE/2018/8175 (H1N1) PDM09 FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2019 |
|
RU2735291C1 |
| VACCINE STRAIN OF INFLUENZA VIRUS A/17/BRISBANE/2018/3610 (H3N2) FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2019 |
|
RU2734897C1 |
| VACCINE STRAIN OF INFLUENZA VIRUS A/17/HONGKONG/2017/75108 (H7N9) FOR PRODUCING POTENTIALLY PANDEMIC LIVE INTRANASAL INFLUENZA VACCINE | 2018 |
|
RU2685121C1 |
| VACCINE STRAIN OF INFLUENZA VIRUS A/17/SLOVENIA/2015/1121 (H1N1)PDM09 FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2019 |
|
RU2724706C1 |
